Pharmacy Alliance

pharmacyalliance.com.au

With the combined strength of more than 650 members and an expert team, Pharmacy Alliance has developed a network of industry partnerships to simplify operating a pharmacy. Our aims are to help make our be more profitable, be competitive and feel like royalty.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA TECH

KSP SPECIALTY PHARMACY NOW OFFERS ACCESS TO NON-ONCOLOGY DRUGS AND LAUNCHES NEW WEBSITE FEATURING PHARMACY PATIENT PORTAL

Karmanos Cancer Institute | October 05, 2021

news image

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient educ...

Read More

BUSINESS INSIGHTS

STANDIGM NAMES CARL FOSTER CHIEF BUSINESS OFFICER TO EXPAND STRATEGIC PARTNERSHIPS FOR AI DRUG DISCOVERY

Standigm | August 19, 2022

news image

Standigm Inc. the leading workflow artificial intelligence (AI) drug discovery company, announced the appointment of Chief Business Officer Carl Foster. Based in our U.S. office, Foster will be responsible for expanding strategic partnerships for novel drug target discoveries and first-in-class lead candidate identifications. "Carl has established a reputation for increasing company value. He has significant experience building and growing biotech ...

Read More

MODERNA, ASTRAZENECA AND J&J CORONAVIRUS SHOTS REV UP FOR NIH TESTS BEGINNING IN JULY: WSJ

Fiercepharma | June 10, 2020

news image

As leading coronavirus vaccines make their way through early stages of human testing, the NIH is plotting much larger efficacy studies this summer. U.S. researchers plan to run phase 3 trials of vaccines from Moderna, AstraZeneca and Johnson & Johnson in the coming months, the Wall Street Journal reports. The NIH intends to start a phase 3 trial of Moderna’s vaccine in July, followed by an August trial of AstraZeneca’s vaccine and a September study of Johnson & Johnson&...

Read More

RESEARCH

PFIZER, MODERNA URGE CALM AS THEY LAUNCH TESTS OF VACCINES AGAINST MUTATED COVID-19

Pfizer | December 29, 2020

news image

After a changed, quick spreading variation of COVID-19 in the U.K. disturbed worldwide travel throughout the end of the week, an upsetting inquiry arose: Will the new antibodies from Pfizer and Moderna neutralize this startling new strain of the infection? Presently the two organizations, alongside Pfizer's COVID-19 accomplice BioNTech, are racing to quiet an apprehensive public. They're dispatching new investigations intended to demonstrate their mRNA-based shots will fig...

Read More
news image

PHARMA TECH

KSP SPECIALTY PHARMACY NOW OFFERS ACCESS TO NON-ONCOLOGY DRUGS AND LAUNCHES NEW WEBSITE FEATURING PHARMACY PATIENT PORTAL

Karmanos Cancer Institute | October 05, 2021

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient educ...

Read More
news image

BUSINESS INSIGHTS

STANDIGM NAMES CARL FOSTER CHIEF BUSINESS OFFICER TO EXPAND STRATEGIC PARTNERSHIPS FOR AI DRUG DISCOVERY

Standigm | August 19, 2022

Standigm Inc. the leading workflow artificial intelligence (AI) drug discovery company, announced the appointment of Chief Business Officer Carl Foster. Based in our U.S. office, Foster will be responsible for expanding strategic partnerships for novel drug target discoveries and first-in-class lead candidate identifications. "Carl has established a reputation for increasing company value. He has significant experience building and growing biotech ...

Read More
news image

MODERNA, ASTRAZENECA AND J&J CORONAVIRUS SHOTS REV UP FOR NIH TESTS BEGINNING IN JULY: WSJ

Fiercepharma | June 10, 2020

As leading coronavirus vaccines make their way through early stages of human testing, the NIH is plotting much larger efficacy studies this summer. U.S. researchers plan to run phase 3 trials of vaccines from Moderna, AstraZeneca and Johnson & Johnson in the coming months, the Wall Street Journal reports. The NIH intends to start a phase 3 trial of Moderna’s vaccine in July, followed by an August trial of AstraZeneca’s vaccine and a September study of Johnson & Johnson&...

Read More
news image

RESEARCH

PFIZER, MODERNA URGE CALM AS THEY LAUNCH TESTS OF VACCINES AGAINST MUTATED COVID-19

Pfizer | December 29, 2020

After a changed, quick spreading variation of COVID-19 in the U.K. disturbed worldwide travel throughout the end of the week, an upsetting inquiry arose: Will the new antibodies from Pfizer and Moderna neutralize this startling new strain of the infection? Presently the two organizations, alongside Pfizer's COVID-19 accomplice BioNTech, are racing to quiet an apprehensive public. They're dispatching new investigations intended to demonstrate their mRNA-based shots will fig...

Read More